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ABSTRACT 
Although the burden of influenza is often discussed in the context of historical pandemics 
and the threat of future pandemics, every year a substantial burden of lower respiratory tract 
infections (LRTIs) and other respiratory conditions (like chronic obstructive pulmonary 
disease) are attributable to seasonal influenza. The Global Burden of Disease Study (GBD) 
2017 is a systematic scientific effort to quantify the health loss associated with a 
comprehensive set of diseases and disabilities. In this Article, we focus on LRTIs that can 
be attributed to influenza. Methods: We modelled the LRTI incidence, hospitalisations, and 
mortality attributable to influenza for every country and selected subnational locations by 
age and year from 1990 to 2017 as part of GBD 2017. We used a counterfactual approach 
that first estimated the LRTI incidence, hospitalisations, and mortality and then attributed a 
fraction of those outcomes to influenza. Findings: Influenza LRTI was responsible for an 
estimated 145 000 (95% uncertainty interval [UI] 99 000–200 000) deaths among all ages 
in 2017. The influenza LRTI mortality rate was highest among adults older than 70 years 
(16·4 deaths per 100 000 [95% UI 11·6–21·9]), and the highest rate among all ages was in 
eastern Europe (5·2 per 100 000 population [95% UI 3·5–7·2]). We estimated that influenza 
LRTIs accounted for 9 459 000 (95% UI 3 709 000–22 935 000) hospitalisations due to 
LRTIs and 81 536 000 hospital days (24 330 000–259 851 000). We estimated that 11·5% 
(95% UI 10·0–12·9) of LRTI episodes were attributable to influenza, corresponding to 54 
481 000 (38 465 000–73 864 000) episodes and 8 172 000 severe episodes (5 000 000–13 
296 000). Interpretation: This comprehensive assessment of the burden of influenza LRTIs 
shows the substantial annual effect of influenza on global health. Although preparedness 
planning will be important for potential pandemics, health loss due to seasonal influenza 
LRTIs should not be overlooked, and vaccine use should be considered. Efforts to improve 
influenza prevention measures are needed. Funding: Bill & Melinda Gates Foundation.  
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